SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-110666
Filing Date
2016-06-30
Accepted
2016-06-30 06:09:18
Documents
9
Period of Report
2016-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v443292_8k.htm 8-K 24813
2 EXHIBIT 1.1 v443292_ex1-1.htm EX-1.1 44607
3 EXHIBIT 4.1 v443292_ex4-1.htm EX-4.1 105263
4 EXHIBIT 5.1 v443292_ex5-1.htm EX-5.1 13450
5 EXHIBIT 10.1 v443292_ex10-1.htm EX-10.1 513857
6 EXHIBIT 99.1 v443292_ex99-1.htm EX-99.1 10817
7 GRAPHIC image_001.jpg GRAPHIC 3214
8 GRAPHIC tlogo1ex5-1.jpg GRAPHIC 13623
9 GRAPHIC tlogoex99-1.jpg GRAPHIC 16507
  Complete submission text file 0001144204-16-110666.txt   760408
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 161740324
SIC: 2834 Pharmaceutical Preparations